Sleeping Beauty-mediated correction of Fanconi anemia type C
- 15 July 2011
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 13 (9) , 462-469
Abstract
Background The Sleeping Beauty (SB) transposon system can insert defined sequences into chromosomes to direct the extended expression of therapeutic genes. Our goal is to develop the SB system for nonviral complementation of Fanconi anemia (FA), a rare autosomal recessive disorder accompanied by progressive bone marrow failure. Methods We used a CytoPulse electroporation system (CytoPulse, Glen Burnie, MD, USA) to introduce SB transposons into human lymphoblastoid cells (LCL) derived from both Fanconi anemia type C (FA-C) defective and normal patients. Correction of the FA-C defect was assessed by resistance to mitomycin C, a DNA-crosslinking agent. Results Culture of both cell types with the antioxidant N-acetyl- l-cysteine improved cell viability after electroporation. Co-delivery of enhanced green fluorescent protein (GFP) transposon with SB100X transposase-encoding plasmid supported a 50- to 90-fold increase in stable GFP expression compared to that observed in the absence of SB100X for normal LCL, but in FA-C defective LCL SB100X enhancement of stable GFP-expression was a more moderate five- to 13-fold. SB-mediated integration and expression of the FA-C gene was demonstrated by the emergence of a mitomycin C-resistant population bearing characteristic transposon-chromosome junction sequences and exhibiting a mitomycin dose response identical to that of normal LCL. Conclusions The SB transposon system achieved stable expression of therapeutic FA-C genes, complementing the genetic defect in patient-derived cells by nonviral gene transfer. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Cytotoxicity Associated with Artemis Overexpression After Lentiviral Vector-Mediated Gene TransferHuman Gene Therapy, 2010
- Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vectorGene Therapy, 2010
- Stable gene transfer and expression in cord blood–derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon systemBlood, 2009
- Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cellsNature, 2009
- Oxidative Stress in Fanconi Anemia Hematopoiesis and Disease ProgressionAntioxidants & Redox Signaling, 2008
- Enzymatic engineering of the porcine genome with transposons and recombinasesBMC Biotechnology, 2007
- Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon‐mediated gene delivery: implications for non‐viral gene therapy of mucopolysaccharidosesThe Journal of Gene Medicine, 2007
- Lack of Self‐Renewal Capacity in Fancc −/− Stem Cells After Ex Vivo ExpansionStem Cells, 2005
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLOS Biology, 2004
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997